Related Articles
The role of CD44+/CD24-/low biomarker for screening, diagnosis and monitoring of breast cancer
Breast cancer stem cells expressing different stem cell markers exhibit distinct biological characteristics
CD44+/CD24‑ phenotype predicts a poor prognosis in triple‑negative breast cancer
Prognostic significance of CD24 and claudin-7 immunoexpression in ductal invasive breast cancer
The Hedgehog signaling pathway is associated with poor prognosis in breast cancer patients with the CD44+/CD24‑ phenotype